News Regarding Low Testosterone
Long-term therapy to treat testosterone deficiency in men may also lower the risk of cardiovascular disease, according to a new study from Boston University Medical Center. To read more about the findings of the study, visit UPI.com.
Men with low testosterone at a greater risk for developing type 2 diabetes. Researchers at Tulane University have, for the first time, identified how testosterone helps men regulate blood sugar by triggering key signaling mechanisms in islets. The findings of this study could help identify new treatments for type 2 diabetes in the large number […]
A new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism indicates that a study of over 9,000 men has defined normal ranges for testosterone levels in men. When applied to appropriately calibrated assays, the reference ranges will enable clinicians to make a correct diagnosis of hypogonadism. To read more about the […]
A new multi-year study from the Intermountain Medical Center Heart Institute in Salt Lake City shows that using testosterone replacement therapy (TRT) to increase testosterone to normal levels in androgen-deficient men doesn’t increase their risk of a serious heart attack or stroke. Testosterone therapy helped elderly men with low testosterone levels and pre-existing coronary artery […]
In middle-aged obese men, losing weight while dieting normally depletes both fat and muscle; however, new research suggests that adding testosterone treatment may help them lose only fat and retain their muscle. To read more about the study, click here.
As they age, men often produce less testosterone than they did in their youth. Men with low testosterone levels may have the following symptoms: fatigue, decreased sexual desire, and difficulty walking. To see if testosterone replacement therapy (TRT) is beneficial in easing such symptoms, NIH started a series of studies called the Testosterone Trials. The […]
Exciting results from a clinical trial of experimental testosterone hormone therapy on men with advanced treatment-resistant prostate cancer. Read more about the study conducted at Johns Hopkins University School of Medicine in Baltimore here.
According to a new study, testosterone replacement therapy (TRT) appears to be safe in hypogonadal prostate cancer patients who have had definitive treatment and in those on active surveillance. Read more at Urology Times.
Men with obesity who have low free testosterone or high estradiol levels are at elevated risk for insulin resistance or developing type 2 diabetes vs. normal-weight men or men with obesity and higher free testosterone levels. Click here for more information.
Long-term testosterone therapy (TT) in hypogonadal men improves urinary function and erectile function compared with untreated controls. To read more about the study’s findings, visit Urology Times.